Milrinone Lactate In Dextrose Injection, Solution
Product Images NDC 68083-410

This is a single-dose, sterile, nonpyrogenic intravenous injection containing Milrinone Lactate in 5% Dextrose. The injection is used as directed by a physician and the package insert must be reviewed before use. It is important to check for leaks before use and must not be used in series connections. It should not be administered simultaneously with blood and it must be used only if the solution is clear and colorless to pale yellow. The product should be stored in a USP controlled room temperature, and should be protected from excessive heat and freezing. The injection is manufactured by Gland Pharma Limited located in Hyderabad, India.*

Milrinone Lactate in 5% Dextrose Injection, manufactured by GLAND PHARMA LIMITED in Hyderabad, India, is an intravenous medication used for patients with congestive heart failure. It contains 20 mg/100 mL or 200 meg (0.2 mg) per mL of Milrinone Lactate and 25.2 mg of Dextrose Hydrous USF in sterile water USF. It is formulated with Lactic acid and/or Sodium Hydroxide to achieve a pH of 3.5. The medication should be used carefully and not be administered simultaneously with blood. It should also not be used in series connections. The package insert contains complete information on dosage and administration. The medication should be stored between 20°C to 25°C (68°F to 77°F) and protected from excessive heat.*

This is a description for Milrinone Lactate in 5% Dextrose Injection, a sterile nonpyrogenic, single-dose container used for medication. The overwrap acts as a moisture barrier while the inner bag maintains the sterility of the product. The injection should not be used if the overwrap has been previously opened or damaged. After removing the overwrap, the container should be checked for minute leaks by squeezing it firmly. If found, the container should be discarded as sterility may be impaired. It is not to be used in series connections or administered simultaneously with blood. The dosage should be as per the package insert. It should be stored at a temperature of 20° to 25°C (68° to 77°F) and protected from excessive heat and freezing. It is manufactured by Gland Pharma Limited in India.*

This is a Milrinone Lactate in 5% Dextrose Injection, with a concentration of 40mg/200mL, and 0.2mg per mL. It is used for intravenous treatment as directed by a healthcare professional. The solution is sterile, nonpyrogenic, and should not have any preservatives added. It should be stored between 20-25°C, protected from freezing and excessive heat. It is manufactured by GLAND Pharma Limited in Hyderabad, India.*

This appears to be a mixture of random text including some medical information about Milrinone Lactate injection in 5% Dextrose for Intravenous use. However, there seems to be insufficient information to generate a useful description, as most of the text is incomplete or unintelligible.*

Milrinone Lactate in 5% Dextrose Injection is a sterile nonpyrogenic, single-dose container that comes in 200 mL volume. The product is not for use if the overwrap has been previously opened or damaged. The overwrap is a moisture barrier that prevents contamination of the product. After opening the overwrap, check for minute leaks by squeezing the container firmly, and discard the unused portion. Do not use in series connections, and do not administer simultaneously with blood. The package insert provides details on the usual dosage. The Milrinone Lactate Injection is manufactured by Gland Pharma Limited in India.*